CIK 0001649989
- Non-accelerated filer
- Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 383982704
- Phone
- +1 609-619-3990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-08 | GMS Tenshi Holdings Pte. Ltd Director | Grant or award · Warrants | +10,256,410 | $0.13 | $1.3M | 20,512,820 |
| 2018-05-14 | GMS Tenshi Holdings Pte. Ltd Director | Grant or award | +6,377,383 | $0.98 | $6.2M | 6,377,383 |
| 2018-05-14 | GMS Tenshi Holdings Pte. Ltd Director | Grant or award · Warrants | +10,256,410 | $0.13 | $1.3M | 10,256,410 |
| 2018-04-13 | THURMAN RANDY H Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-03-31 | GMS Tenshi Holdings Pte. Ltd Director | Other acquisition · Series A Convertible Preferred Stock | +6,367 | 261,045 | ||
| 2018-03-23 | Windisch Joerg Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2018-01-04 | Mohan Pankaj President & CEO | Sale | −62,569 | $1.16 | $73K | 7,056,553 |
| 2018-01-03 | Mohan Pankaj President & CEO | Sale | −52,108 | $1.18 | $61K | 7,119,122 |
| 2017-12-31 | GMS Tenshi Holdings Pte. Ltd Director | Other acquisition · Series A Convertible Preferred Stock | +4,678 | 254,678 | ||
| 2017-12-22 | Yamashita Elizabeth A. VP, Regulatory Affairs | Sale | −16,170 | $1.13 | $18K | 64,648 |
| 2017-12-22 | Bahrt Kenneth Chief Medical Officer | Sale | +26,165 | $1.13 | $30K | 54,820 |
| 2017-12-22 | MCANDREW STEPHEN J SVP Bus. Strat. & Dev. | Sale | +15,705 | $1.13 | $18K | 50,899 |
| 2017-12-22 | KENYON LAWRENCE A CFO and Secretary | Sale | −26,165 | $1.13 | $30K | 67,313 |
| 2017-12-19 | Mohan Pankaj President & CEO | Sale | −83,608 | $1.14 | $95K | 7,171,230 |
| 2017-12-19 | Yamashita Elizabeth A. VP, Regulatory Affairs | Sale | −6,151 | $1.14 | $7K | 80,818 |
| 2017-12-18 | Mohan Pankaj President & CEO | Sale | −20,523 | $1.17 | $24K | 7,254,838 |
| 2017-12-18 | Yamashita Elizabeth A. VP, Regulatory Affairs | Sale | −1,509 | $1.17 | $2K | 86,969 |
| 2017-10-31 | Albrecht Claudio Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-10-31 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2017-10-31 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 |
Page 17 of 20 · 386 trades